Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Lexaria Bioscience (LEXX) over the last 15 years, with Q4 2025 value amounting to $850585.0.

  • Lexaria Bioscience's Prepaid Assets rose 9152.1% to $850585.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $850585.0, marking a year-over-year increase of 9152.1%. This contributed to the annual value of $1.1 million for FY2025, which is 465.67% down from last year.
  • Latest data reveals that Lexaria Bioscience reported Prepaid Assets of $850585.0 as of Q4 2025, which was up 9152.1% from $1.1 million recorded in Q3 2025.
  • In the past 5 years, Lexaria Bioscience's Prepaid Assets ranged from a high of $1.2 million in Q3 2024 and a low of $132311.0 during Q4 2023
  • In the last 5 years, Lexaria Bioscience's Prepaid Assets had a median value of $495452.0 in 2023 and averaged $568528.1.
  • In the last 5 years, Lexaria Bioscience's Prepaid Assets surged by 46170.92% in 2021 and then crashed by 7151.5% in 2023.
  • Over the past 5 years, Lexaria Bioscience's Prepaid Assets (Quarter) stood at $237223.0 in 2021, then grew by 9.75% to $260342.0 in 2022, then plummeted by 49.18% to $132311.0 in 2023, then soared by 235.66% to $444121.0 in 2024, then soared by 91.52% to $850585.0 in 2025.
  • Its Prepaid Assets was $850585.0 in Q4 2025, compared to $1.1 million in Q3 2025 and $823348.0 in Q2 2025.